Simplex Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-52
| Closed | -$504K | – | 8393 |
|
|
2019
Q3 | $504K | Sell |
52
-323
| -86% | -$32.3K | ﹤0.01% | 2616 |
|
|
2019
Q2 | $3.84M | Buy |
375
+46
| +14% | +$4.96K | 0.01% | 840 |
|
|
2019
Q1 | $3.75M | Buy |
329
+239
| +266% | +$17.6K | 0.01% | 880 |
|
|
2018
Q4 | $352K | Buy |
90
+3
| +3% | +$130 | ﹤0.01% | 2556 |
|
|
2018
Q3 | $474K | Buy |
87
+31
| +55% | +$2.12K | ﹤0.01% | 2686 |
|
|
2018
Q2 | $463K | Sell |
56
-111
| -66% | -$8.57K | ﹤0.01% | 2535 |
|
|
2018
Q1 | $133K | Sell |
167
-208
| -55% | -$12K | 0.01% | 1570 |
|
|
2017
Q4 | $195K | Buy |
375
+43
| +13% | +$3.09K | 0.01% | 1293 |
|
|
2017
Q3 | $116K | Sell |
332
-138
| -29% | -$10.5K | ﹤0.01% | 1595 |
|
|
2017
Q2 | $240K | Buy |
+470
| New | +$26.3K | 0.01% | 1083 |
|
|
2016
Q4 | – | Sell |
-13
| Closed | -$12K | – | 6887 |
|
|
2016
Q3 | $12K | Sell |
13
-156
| -92% | -$8.99K | ﹤0.01% | 3486 |
|
|
2016
Q2 | $88K | Buy |
+169
| New | +$7.22K | 0.01% | 1576 |
|
|
2015
Q4 | – | Sell |
-502
| Closed | -$166K | – | 6486 |
|
|
2015
Q3 | $166K | Buy |
502
+467
| +1,334% | +$24.4K | 0.01% | 1046 |
|
|
2015
Q2 | $32K | Sell |
35
-24
| -41% | -$1.59K | ﹤0.01% | 2051 |
|
|
2015
Q1 | $25K | Buy |
+59
| New | +$3.4K | ﹤0.01% | 2157 |
|
Simplex Trading's ONCE Position: Q3 2019 in Review
Simplex Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 221 shares — an estimated $22.1K sold.
Simplex Trading first reported a position in ONCE in Q4 2015 and held it in 11 quarters. The position peaked at $4.93M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.
- Simplex Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 221 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $22.1K.
- Simplex Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
- Simplex Trading's Spark Therapeutics, Inc. Common Stock position peaked at $4.93M in Q1 2019.
- 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.